An integrated system to study multiply substituted human immunodeficiency virus type 1 reverse transcriptase

被引:51
作者
Boretto, J
Longhi, S
Navarro, JM
Selmi, B
Sire, J
Canard, B
机构
[1] CNRS, UMR 6098, F-13288 Marseille 09, France
[2] Univ Aix Marseille 1, ESIL, CNRS, AFMB, F-13288 Marseille, France
[3] Univ Aix Marseille 2, ESIL, AFMB, CNRS, F-13288 Marseille 09, France
[4] INSERM, U372, F-13288 Marseille 09, France
关键词
D O I
10.1006/abio.2001.5045
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We describe a gene system allowing the facile production of multiply substituted reverse transcriptases (RTs), the enzymatic characterization of these purified RTs, and the study of these mutations in the defined genetic background of the macrophage-tropic, non-laboratory-adapted human immunodeficiency virus type 1 (HIV-1) AD8 strain. Thirteen unique silent restriction sites were introduced in the pol gene encoding HIV-1 RT, allowing easy introduction of mutations. To simplify genetic manipulation and generate p66/p51 heterodimers in Escherichia coli, a gene construct of the viral protease alone was optimized for expression from a separate vector carrying a p15A origin of replication. Acitve-site titration experiments using pre-steady-state kinetics showed that our system yields a higher proportion of active enzyme than that obtained by alternate methods. To facilitate phenotype/genotype correlations, the modified RT gene was designed to be easily reintroduced into a recombinant proviral AD8 HIV-1 DNA, Infectious viruses made from this vector were undistinguishable from wild-type AD8 HIV-1, an isolate able to infect peripheral blood mononuclear cells and macrophages, Thus, the pot gene can tolerate many silent mutations in the polymerase domain without affecting the functionality of the HIV-1 genome. The system was validated biochemically and virologically using the V75T substitution associated with stavudine resistance. (C) 2001 Academic Press.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 21 条
[11]   SUBUNIT-SELECTIVE MUTAGENESIS INDICATES MINIMAL POLYMERASE-ACTIVITY IN HETERODIMER-ASSOCIATED P51 HIV-1 REVERSE-TRANSCRIPTASE [J].
LEGRICE, SFJ ;
NAAS, T ;
WOHLGENSINGER, B ;
SCHATZ, O .
EMBO JOURNAL, 1991, 10 (12) :3905-3911
[12]  
LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x
[13]   STRUCTURAL CHARACTERIZATION OF REVERSE-TRANSCRIPTASE AND ENDONUCLEASE POLYPEPTIDES OF THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME RETROVIRUS [J].
LIGHTFOOTE, MM ;
COLIGAN, JE ;
FOLKS, TM ;
FAUCI, AS ;
MARTIN, MA ;
VENKATESAN, S .
JOURNAL OF VIROLOGY, 1986, 60 (02) :771-775
[14]   RECOMBINANT HIV-1 REVERSE-TRANSCRIPTASE - PURIFICATION, PRIMARY STRUCTURE, AND POLYMERASE RIBONUCLEASE-H ACTIVITIES [J].
MIZRAHI, V ;
LAZARUS, GM ;
MILES, LM ;
MEYERS, CA ;
DEBOUCK, C .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1989, 273 (02) :347-358
[15]  
MULLER B, 1991, J BIOL CHEM, V266, P14709
[16]  
RESTLE T, 1990, J BIOL CHEM, V265, P8986
[17]  
Schinazi R, 2000, INT ANTIVIRAL NEWS, V8, P65
[18]  
Stahlhut MW, 1996, METHOD ENZYMOL, V275, P122
[19]   Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions [J].
Theodore, TS ;
Englund, G ;
BucklerWhite, A ;
Buckler, CE ;
Martin, MA ;
Peden, KWC .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (03) :191-194
[20]   CHARACTERIZATION OF HIGHLY IMMUNOGENIC P66 P51 AS THE REVERSE-TRANSCRIPTASE OF HTLV-III LAV [J].
VERONESE, FD ;
COPELAND, TD ;
DEVICO, AL ;
RAHMAN, R ;
OROSZLAN, S ;
GALLO, RC ;
SARNGADHARAN, MG .
SCIENCE, 1986, 231 (4743) :1289-1291